Together with an earlier report indicating decreased expression levels of AP‐2α in the AD brain 71, our findings suggest that AP‐2 changes observed in TREM2R47H‐carrying AD patients could partially be responsible for increased amyloidogenic processing of APP in the AD brain. The gene discussed is APP; the disease is Alzheimer disease.